Who we are
Our mission is to help improving the outcome of patients suffering (or at risk of suffering) from cardioneurovascular diseases.
Emosis develops and provides physicians with first-in-class, on demand, and user-friendly extended in vitro diagnostic products, centered on lab assay kits to be routinely performed on the rapidly growing new generation of flow cytometers, including highly automated, compact benchtop devices.
These products aim at providing a comprehensive blood test panel for the bioclinical investigation of vascular thrombosis-induced or complicated diseases, in which clots formed in veins or arteries impede or block the blood flow to the heart, lungs, brain or other organs.
These tests whose development is rooted in the unfolding of thrombosis biological complexity, aim at informing physician medical decision making with respect to thrombotic events or risk in a broad range of clinical settings, such as coronary disease, arteritis, deep venous thrombosis, cancer, COVID-19, pregnancy and pharmacological and non-pharmacological therapies.
Our head office is located in Illkirch-Graffenstaden, France, close to the German and Swiss borders, and we have a subsidiary in Tel Aviv, Israel.
What drives us
Creativity & global innovation
Openness & respect
Professionalization of our young employees, then recruited on permanent contract
Employee saving plan leading to an employee shareholding
ISO 9001:2015 and ISO 13485:2016 certifications
Digital quality management system
Some of our talents
The wealth of a company lies in its people. At Emosis, we add: and in its atypical talents, an obvious source of value. Here are some of them.
"Emosis offers that kind of work environment that allows me to grow, whether it is to increase my autonomy, my responsibilities, or my versatility."
Justine Catella / Communication Manager - Complete story
"I am convinced of the positive impact of new diagnostic methods and / or technologies on our health. I found the Emosis HIT Confirm kit approach very interesting; the multiplicity of issues related to hemostasis disorders opening up many avenues for innovation."
Anne Runser / R&D Project Manager - Complete story
"Emosis has a very modern vison of the implication of statistics in biological research.
Its ambition - which I fully support - is the development of augmented diagnostics. Artificial intelligence would increase the quality of the doctor's decision by offering diagnoses supplemented by adapted visualization allowing the doctor to question his own approach."
Matthieu Stoll / Emosis Statistician - Complete story
"I decided to join Emosis based on the desire to work and leave a footprint in Diagnostics, with new types of products (cell-based, using flow cytometry) within a young start-up in a field (hemostasis) where I could bring my experience and network in both Sales and Marketing."
Nicolas Rufin / Emosis Sales & Marketing - Complete story
A multinational and multidisciplinary 360° management team, highly experienced in the healthcare, hemostasis and hematology industries.